HN and L2S2 have announced their collaboration that aims to deliver services that support the challenges of modern healthcare.
Mark England, HN’s CEO said: “Our partnership with L2S2 is proving to be extremely important. Their values are aligned with our own, with strong integrity and patient focus.
L2S2’s approach to continual compliance within the healthcare domain is leading edge and the opportunity to work together means we can both achieve more. L2S2 have intuitive platforms that enable us to continue on our mission to support the NHS, empower patients and secure sustainable healthcare for all.”
L2S2’s Managed Medical Device Cloud (MMDC) provides HN with access to data security and a medical device grade digital health solution. Coupled with HN’s evidence-based clinical interventions and AI capabilities in building predictive models on real-time operational data, it aims to give patients and clinicians the confidence in the remote healthcare delivery model.
This technology forms the foundation of HN Virtual CARE – a virtual ward solution, providing NHS at home services. By using L2S2’s smart remote patient monitoring technology with clinical coaching, the service can allow local NHS systems to deploy a staffed ‘out of the box’ virtual ward.
The model is extensible and scalable, relevant for many pathways, particularly for same day emergency care or Oximetry at Home, where patients can be observed and supported at home.
Jane Aldridge, L2S2’s co-founder said: “We are very pleased to be working with HN on this project. The combination of L2S2’s remote patient monitoring platform and HN’s clinical coaching enables this collaboration to deliver staffed virtual wards, which will help to reduce strain on the NHS while delivering a high level of care to patients. This is a solution of the future, delivered today.”
